The nephroprotective effect of SFN was abolished in podocyte-specific Nrf2 cKO mice, suggesting that SFN mitigates DM-induced podocyte damage through the Nrf2/PINK1 axis. The gene discussed is SFN; the disease is diabetes mellitus.